Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “SPLEEN”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 469 records · Page 26Linked to original sources
PubMed1987

Comparative analysis of galactoside-binding lectins isolated from mammalian spleens.

Galactoside-inhibitable lectins have been isolated from rabbit, rat, mouse, pig, lamb, calf, and human spleens. Native molecular mass, subunit structure, pI, and hemagglutinating activity have been compared for these lectins. The yields of lectin varied from 1.8 mg/kg for rabbit spleen to 79 mg/kg for lamb spleen. Pig, lamb, calf, and human spleen lectins yielded single protein peaks when subjected to Superose 12 fast-protein liquid chromatography. The apparent molecular mass for these lectins was 33-34 kDa. In contrast, rat and mouse spleen lectin preparations were separated into three components ranging from 8.4 to 34 kDa. Superose 12 chromatography of rabbit spleen lectin revealed the presence of at least six components. Gradient slab gel sodium dodecyl sulfate-polyacrylamide gel electrophoresis showed the presence of single polypeptides for pig, calf, lamb, and human lectins corresponding to a molecular mass of 14-14.5 kDa. Multiple polypeptides were detected for the mouse, rat, and rabbit lectins. The molecular mass of the major polypeptides were 15, 15, and 17 kDa for rat, mouse, and rabbit, respectively. The presence of isolectins in all preparations was shown by isoelectric focusing. The major isolectins were acidic proteins with pI 4.38-4.80. Hemagglutination and hemagglutination inhibition assays demonstrated similarities as well as differences among the lectin preparations. Hemagglutinating activity could not be demonstrated in rabbit spleen extracts nor for isolated putative lectin. Human buffy coat cells were reversibly agglutinated by calf and human spleen lectins, demonstrating the presence of leucocyte cell surface lectin receptors.

Animals↗
PubMed1987

Specific suppression of the in vitro parent anti-hybrid reaction. I. Characterization of a suppressor cell induced in hybrids by pretreatment with parent-strain spleen cells.

Spleen cells from B6D2F1 hybrid mice pretreated with 5 X 10(7) B6 spleen cells iv 7 days earlier (B6-pretreated B6D2F1) exhibit a reduced capacity to stimulate the in vitro proliferative and anti-D2 CTL responses of B6 spleen cells. This inability of B6-pretreated B6D2F1 spleen cells to stimulate B6 spleen cells efficiently is due neither to the absence of stimulating cells bearing the D2 alloantigens nor to the destruction of B6 responding cells, but to the presence in the B6-pretreated B6D2F1 cell population of a suppressor mechanism, since the addition of B6-pretreated B6D2F1 spleen cells to a culture of normal B6 responding and irradiated B6D2F1-stimulating spleen cells can suppress the B6 anti-B6D2F1 response. This suppression is mediated by a nylon adherent, Thy-1-negative cell of parent-strain origin which is radioresistant at 2000 R. This suppressor cell is not induced by the injection to B6D2F1 hybrids of spleen cells from the other parent strain (D2) or an allogeneic strain (C3H). It does not suppress either the response of the other parent (D2) or an allogeneic strain (C3H) to B6D2F1 antigens, or the response of B6 cells to an allogeneic strain (C3H).

Animals↗
PubMed1988

Norepinephrine and serotonin content of the murine spleen: its relationship to lymphocyte beta-adrenergic receptor density and the humoral immune response in vivo and in vitro.

Numerous reports in the literature describe the effects of beta-adrenergic agonists and/or their second messenger cyclic AMP on in vitro and in vivo immune responses. The fact that the murine spleen receives rich adrenergic innervation and that the pharmacologic disruption of this innervation leads to altered immune responsiveness has led some investigators to postulate that the immune system may be modulated in vivo by the sympathetic nervous system. In this report HPLC is used to quantitate the norepinephrine (NE) and serotonin (5-HT) found in the B6C3F1 spleen. These transmitters were found to be distributed nonhomogeneously among the cell, supernatant, and capsule fractions of the spleen. The majority of NE was found in the capsule while most 5-HT was found associated with the cell pellet. During an immune response to sheep red blood cells the concentration of NE in the spleen was found to be decreased. However, the total amount of splenic NE was unaltered and thus the decreased concentration may be attributed to the increased weight of immunized spleens. Simultaneously, the total amount of the dopamine metabolite 3,4-dihydroxyphenylacetic acid found in the spleen was found to be increased, a difference not explained by increased spleen size. These results suggest an antigen-induced increase in sympathetic activity in the spleen. Splenic NE could be rapidly depleted using 6-hydroxydopamine. Lymphocytes from the NE-depleted animals were found to have upregulated the number of beta-adrenergic receptors on their surfaces and demonstrated a reduced ability to respond to sheep red blood cells in vitro.

3,4-Dihydroxyphenylacetic Acid↗
PubMed1992

A longitudinal study of age-related loss of noradrenergic nerves and lymphoid cells in the rat spleen.

A longitudinal study of sympathetic noradrenergic (NA) innervation of the spleen was carried out in 3-, 8-, 12-, 17-, 21-, and 27-month-old Fischer 344 (F344) rats using (i) fluorescence histochemistry for localization of norepinephrine (NE); (ii) immunocytochemistry (ICC) for localization of tyrosine hydroxylase (TH)-positive nerve fibers alone, and in combination with specific markers for T and B lymphocytes (OX19 and anti-mu respectively), and macrophages (ED3); and (iii) high-performance liquid chromatography with electrochemical detection for quantitation of NE. Fluorescence histochemistry revealed extensive loss of NA nerve fibers in all compartments of the spleen in 21- and 27-month-old rats. With single-label ICC, a decline in TH+ nerve fibers in all compartments of the spleen was observed by 17 months of age and became more severe with advancing age; these findings suggest that both the rate-limiting enzyme and the transmitter itself (NE) are depleted from sympathetic nerves in aged rat spleen. Double-label ICC demonstrated the loss of TH+ nerve fibers in spleen from 17-, 21-, and 27-month-old rats, and a parallel loss of OX19+ T lymphocytes and ED3+ macrophages in these cellular compartments. Neurochemical measurement of NE demonstrated a decline in NE per wet weight at 27 months of age. The age-related decline in NA innervation of spleen and in the density of specific populations of cells of the immune system (T lymphocytes and antigen-presenting ED3+ macrophages), that follow remarkably similar time courses, supports functional evidence for dynamic interactions between the immune system and NA sympathetic nerves in the spleen, and further suggests a causal relationship between these age-related phenomena, i.e., that age-related immunosenescence promotes sympathetic denervation of the spleen which further compromises immune function. This hypothesis, however, requires further testing.

Aging↗
PubMed1995

Micronucleus formation induced by three polycyclic aromatic hydrocarbons in rat bone marrow and spleen erythrocytes following intratracheal instillation.

Benz[a]anthracene (BA), dibenz[a,h]anthracene (DBA) and dibenzo[a,i]pyrene (DBP) are polycyclic aromatic hydrocarbons (PAHs) found in incomplete combustion products of fossil fuels, coal tar, and other organic materials. Workers in related industries may be exposed to these chemicals by inhalation. The information related to the potential health hazards of these chemicals to the exposed workers, however, is very limited. In the present study, micronucleus (MN) formation in rat bone marrow and spleen polychromatic erythrocytes (PCEs) was determined following three intratracheal instillations within a 24-h period with either BA, DBA or DBP. Three doses with five rats per dose were used for each chemical. Bone marrow and spleen cells were harvested 24 h after the first dosing. Results showed that the order of toxicity for the three PAHs was DBP > DBA > BA. BA induced MN in a dose-related manner in both bone marrow and spleen PCEs at doses above 25 mg/kg. DBA caused significant increases in the frequencies of MN in both spleen and bone marrow PCEs at the dose of 8.5 mg/kg or higher. At 10 mg/kg, DBP significantly increased MN frequency in spleen PCEs, but the increase in bone marrow PCEs was not significantly different from the control. These results indicate that: (1) all three PAHs studied are absorbed through the respiratory tract and their genotoxic metabolites reach the bone marrow and/or spleen; (2) except for DBP which does not induce MN in the bone marrow, all three PAHs induced MN in both bone marrow and spleen PCEs; and (3) the sensitivity of the spleen to the three PAHs is comparable to or higher than that of the bone marrow.

Air Pollutants, Occupational↗
PubMedDate not supplied

Age-related refractoriness of PHA-induced lymphocyte transformation. II. 125-I-PHA binding to spleen cells from young and old mice.

Using 125-I-labelled red kidney bean phytohemagglutinin (125-I-PHA), we have found that spleen cells from old BC3F1 mice bind this plant mitogen equally well, if not better, than spleen cells from young BC3F1 mice, although PHA-induced blastogenesis of spleen cells from old mice is sharply reduced. Analyes demonstrated that there is neither significant alteration of binding affinity nor decreased total number of membrane receptor sites for PHA in senescing mouse spleen cells. The amount of PHA which was initially bound to spleen cells in serum-free medium appeared to be insufficient for a subsequent full stimulation of blastogenesis ([3-H]thymidine incorporation) in either young or old mouse spleen cells; when washed free of unbound extracellular PHA and upon clutivation in serum-containing culture medium, spleen cells rapidly released more than 90% of the bound PHA. Also, temperatures which change cell membrane morphology played a significant role in the binding and retention of PHA. However, no difference was observed between young and old mouse spleen cells in all these phenomena of PHA-cell membrane interaction.

Aging↗
PubMed1983

Age-dependent changes in the cellularity and ultrastructure of the spleen of Fischer F344 rats.

The age-related changes in the cellularity (cells/gram of tissue) of the spleens and thymuses of Fischer F344 male rats were determined. A decline in the weight of the thymus with age was observed as previously reported by others. The decline was most drastic between 4 and 20 months of age. The spleen, however, increased in weight with age. The increase was almost linear between 4 and 30 months of age. Yet when the number of cells recovered from each organ as a function of age was determined, a decrease for both the thymus and the spleen was observed with increasing age. It was surprising to find that fewer cells were recovered from the spleens of old animals even though the weight of the spleen of the old animals was greater than the spleens from the younger animals. The ultrastructure of the splenic white pulp of rats ranging from 4 to 30 months of age was studied to determine the possible cause for the age-related decrease in cellularity of the spleen. The white pulp of the 4-month-old rats contained a large number of small lymphocytes, and the number of cells was found to decrease with increasing age. The 30-month-old animals had less than 20% the number of lymphocytes in the white pulp as the 4-month-old animals, and the white pulp exhibited an increased number of reticular cells and macrophages with enlarged cytoplasm. The decreased cellularity and increased structural disturbance might be significant in the age-related decline of spleen lymphocyte functions.

Aging↗
PubMed1995

An in vivo/in vitro method for assessing micronucleus and chromosome aberration induction in rat bone marrow and spleen. 2. Studies with chlorambucil and mitomycin C.

An in vivo/in vitro system using rat bone marrow cells and spleen cells to assess micronucleus (MN) and structural chromosome aberrations (SCA) simultaneously (Moore et al., 1995) was further developed. In two separate experiments, two rats/dose/experiment were treated i.p. with 0, 5, 10 and 15 mg chlorambucil (CA)/kg or with mitomycin C (MMC) at 0, 1, 2, 4 mg/kg (experiment 1) or 0, 4, 6, and 8 mg/kg (experiment 2) and killed 6 h later. Cultures were then established in the presence of growth stimulants (interleukin-3 and granulocyte-macrophage colony stimulating factor for bone marrow; lipopolysaccharide and concanavalin A for spleen) and cytochalasin B, a cytokinesis inhibitor. Bone marrow cells were harvested 24 h after establishment of cultures, while spleen cells were harvested at 48 h. In addition, spleen cells were concurrently assayed for chromosome aberrations. With the MN endpoint, spleen cells appeared more sensitive than bone marrow cells to the effects of CA due both to a lower background and an increased response. For MMC, bone marrow cells exhibited both a higher background of MN and a greater numerical response than did spleen cells. However, on the basis of a fold-increase over control values, spleen cells were more sensitive than bone marrow cells. In general, the MN endpoint appeared more sensitive than the SCA in spleen cells after treatment with CA or MMC. Thus, the approach described here shows greater potential in detecting genotoxicity.

Animals↗
PubMed1994

Distribution of lymphocyte subpopulations in thymus, spleen, and peripheral blood of specific pathogen free pigs from 1 to 40 weeks of age.

Using flow-microfluorometry analysis and cluster determinant (CD) markers, we studied how lymphocyte subpopulations in lymphoid organs of specific-pathogen-free pigs developed in pigs from birth to young adulthood. Cell suspensions of the thymus and spleen were prepared and peripheral blood cells were collected at 1, 4, 10, and 40 weeks of age. Tissue sections of the thymus and spleen were stained with monoclonal antibodies directed against CD2 and immunoglobulin to localize the CD2-Ig- lymphocyte subpopulation. In the thymus, only limited changes were observed in the lymphocyte subpopulations with time. Most thymocytes expressed CD4 or CD8 or both. Most CD2-Ig- cells or, 'null cells', (5-13%) were observed in the medulla of the thymus and probably represented a recirculating cell type. In the spleen and blood the percentage of CD2+ and Ig+ cells increased significantly with time, the former increasing from about 30-60% owing to an increase of CD8+ cells. Therefore, the selective increase of the CD8+ population also caused the CD4/CD8 ratio to change. Although CD2+ cells in the spleen and blood are positive for CD4 or CD8, but not for both, quantities of CD4+ CD8+ cells were also observed. Half of the lymphocytes in the spleen and blood were typed as null cells at 1 week of age and decreased in proportion to the increase of the CD8+ and Ig+ cells. Nevertheless, quantities of null cells were still present in the spleen blood at 40 weeks of age. Almost all these were located in the red pulp of the spleen. This study indicates an effect of age and housing conditions on the distribution of the lymphocyte subpopulations, and especially on the CD8+ subset. Quantities of CD4+CD8+ cells as well as CD4-CD8- were observed in blood, but also in spleen of pigs. The function of high numbers of null cells directly after birth are discussed.

Aging↗
PubMed1989

Persistent infection of mice by lactate dehydrogenase-elevating virus: transient virus replication in macrophages of the spleen.

In order to assess whether the spleen is the major site of replication of lactate dehydrogenase-elevating virus (LDV) in mice during the acute phase of infection, LDV replication in the spleen was measured by electron microscopy and fluorescent antibody staining of tissue sections and northern hybridization of total spleen RNA with an LDV-specific cDNA probe, and the effect of splenectomy on LDV replication was determined. LDV RNA and antigens and infected cells, presumably macrophages, were present in the spleen in high concentrations 18-25 h post infection, but then rapidly disappeared to undetectable levels during the next 1-2 days. Thus, LDV clearly replicates in the spleen during the initial phase of infection, but LDV replication in the spleen is transient due to the cytocidal nature of LDV replication and destruction of all permissive macrophages in the spleen. Furthermore, spleen macrophages do not seem to represent the major source of LDV released into the circulation, since LDV viremia as well as anti-LDV antibody production were the same in splenectomized and control animals for at least 28 days postinfection.

Animals↗
PubMed1986

Differences in the effect of indomethacin and preincubation on the lymphoproliferative response to concanavalin A of spleen cells from low responder C57BL/6 and high responder BALB/c mice.

In vivo treatment with 100 micrograms of indomethacin each 48 h for 2 weeks enhanced the proliferative response to concanavalin A (Con A) of spleen cells from mice of the C57BL/6 (B6) strain, low responder to T cell mitogens, but did not modify the response of spleen cells from mice of the high responder strain BALB/c (C). The enhancing effect of in vivo indomethacin treatment was more marked in cultures of B6 splenocytes stimulated with high, moderately supraoptimal doses of Con A than in cultures stimulated with optimal mitogen doses. Addition of indomethacin to cultures of spleen cells from untreated donors induced greater increase of the lymphoproliferative response of cells from low responder B6 than from high responder C mice. The enhancing effect of indomethacin added in vitro was observed in cultures stimulated by optimal but not by supraoptimal doses of Con A. The addition of indomethacin did not enhance the response of B6 spleen lymphocytes depleted of adherent cells. Preincubation for 24 h prior to mitogen stimulation increased the response to high Con A doses of spleen cells from low responder B6 mice whereas this procedure did not enhance lymphocyte proliferation in cultures of spleen cells from high responder C mice. Supplementation with indomethacin in vitro combined with preincubation induced additive enhancing effects on DNA synthesis by B6 spleen lymphocytes, suggesting that each treatment acts through different mechanism(s). The results indicated that spleen cells from low responder B6 strain mice are more sensitive than cells from high responder C mice to the potentiating effect of indomethacin and preincubation on the proliferative response to Con A. These observations suggest that mechanisms sensitive to indomethacin and to preincubation contribute to the depression of mitogen induced DNA synthesis in low responder B6 mice.

Animals↗
PubMed1996

Dose-response relationships of cytotoxicity, PFC response and histology in the spleen in rats treated with alkylating agents.

Our previous study revealed the appropriate conditions for the plaque- forming cell (PFC) assay in rats. Using this assay in the present study, dose-response relationships of cytotoxicity, PFC response and histology in the spleen were evaluated in rats receiving alkylating agents. Rats were given a single intravenous administration of cyclophosphamide (CY) at a dose of 3, 10 or 30 mg/kg. Spleen weights and cellularity were decreased in the rats treated with 30 mg/kg. Suppressed PFC response wes observed in the rats receiving 10 mg/kg or more. In the rats treated with CY at 1, 3 or 10 mg/kg for 7 days, spleen weights and cellularity and PFC response were reduced at doses of 3 mg/kg or more. Treatment with the other alkylating agents, however, had a different consequence. Namely, in the rats treated with nitromin once or for 7 days, spleen weights and cellularity were decreased at a dose lower than that causing a reduction in the PFC response. In the rats treated with melphalan or chlorambucil, the weights and cellularity of the spleen tended to be decreased at a dose lower than that suppressing the PFC response. Histologically, in the case of CY, the marginal zone was narrow with cellular depletion in the rates receiving 3 mg/kg, whereas little change was seen in the periarteriolar lymphoid sheath (PALS). At a dose of 10 mg/kg, the marginal zone was markedly atrophied and slight atrophy of the PALS was seen. On the other hand, in the rats treated with nitromin, a dose-related decrease in the size of the spleen was seen without changes in the tissue architecture. Melphalan caused atrophy of both the marginal zone and the PALS at a dose suppressing PFC response. Regarding the red pulp, the extramedullary hematopoiesis disappeared with melphalan and nitromin, but not with CY. These results indicate that the decreases in weights and cellularity and histological changes in the spleen caused by the alkylating agents are detectable at the dose suppressing PFC response except for CY, which has a marked immunosuppressive action. Furthermore, the observed histological findings in the spleen were characteristic of each alkylating agent.

Animals↗
PubMed1986

Cytolysis of Junin infected target cells by immune guinea pig spleen cells.

Spleen cells from guinea pigs infected with an attenuated strain of Junin virus (the causative agent of Argentine hemorrhagic fever) specifically lysed virus-infected syngeneic target cells in vitro. This activity was detected as early as 6 days after infection, reached a maximum on days 10-13, and persisted at lower levels, at least through day 30. Monoclonal antibody to guinea pig T cells had no effect on the activity. After B or T cell enrichment techniques, the cytolysis was found with the B cell fraction. Aggregated IgG blocked the cytolysis. These characteristics suggested lytic activity was mediated at least in part by an antibody-dependent cell-mediated cytotoxicity (ADCC) mechanism. Although some cytolysis could be detected by using exogenously added antiserum and normal spleen effector cells, such reconstruction showed less efficient killing than when spleen cells from Junin-infected guinea pigs were used. This apparent discrepancy was resolved when spleen cells from these infected animals exhibited enhanced activity in non-viral ADCC systems as well. The cytotoxic activity by spleen cells against Junin-infected targets was detected only with non-fatal Junin infections. Cytolysis could not be measured in spleen cell suspensions from guinea pigs lethally infected with Junin virus; i.e. adults infected with a virulent strain of Junin and baby guinea pigs or immunosuppressed adult animals infected with an attenuated strain. However, spleen cells from both the immunosuppressed, infected adults and the adult guinea pigs infected with a virulent strain of Junin were able to mediate cytotoxicity in a nonviral system (antibody-sensitized Vero cells). The development of spleen cell cytotoxicity by Junin-infected guinea pigs against Junin-infected target cells correlated with whether the infection was resolved or was lethal.

Animals↗
PubMed1994

A new option for splenic preservation in normal sized spleen based on preserved histology and phagocytic function of the upper pole using upper short gastric vessels.

Despite the recognized desirability of splenic salvage, forced splenectomy remains the rule in many operative situations, including trauma and pancreatic cancer. An anatomic study was conducted to assess whether the upper short gastric arteries provide sufficient collateral circulation to the spleen that the upper pole could remain viable even when the hilum is resected and the splenic artery and vein no longer intact. The anatomy of the upper short gastric vessels was studied in 59 human spleens and 18 albino rat spleens. Fifty-four human specimens (92%) and 18 (100%) of the rat spleens showed at least 1 upper short gastric artery and 1 vein connecting the fundus of the stomach with the interior of the upper pole of the spleen with no connection to the major hilar vessels. Lower two-thirds splenectomy, which included excision of the hilum of the spleen after ligation of both the splenic artery and vein, was performed on 14 of the 18 rats. The remaining 4 rats served as control animals. The upper pole of the spleen was preserved solely on the upper short gastric vessels that pass directly between the stomach and the interior of the spleen. Structure and macrophage function in the residual splenic tissue was shown to be preserved at 1 hour and 2 weeks postoperatively, based on results of the India ink technique for demonstrating phagocytic function and on results of regular histologic examination. Preservation was attributed to the fact that blood supply for the residual splenic tissue after splenic mass reduction remained adequate through the upper short gastric vessels. Splenic mass reduction is essential to improve perfusion to the residual splenic tissue if excision of the splenic hilum or ligation of the main splenic vessels becomes an operative necessity.

Animals↗
PubMed1988

A novel growth factor in rat spleen which promotes proliferation of hepatocytes in primary culture.

We have identified a factor from adult rat spleen which stimulates the proliferation of rat hepatocytes. The activity was found in the spleen soluble matrix fraction (1,300xg supernatant of inter-cellular fraction). No activity was found in the spleen cell homogenate, in the spleen insoluble matrix fraction or rat serum. After 4 days of incubation with the spleen factor, the cell number increased 4-fold higher than that at inoculation. The growth stimulation were observed in both fetal bovine serum supplemented medium and hormonally defined medium which contains insulin, epidermal growth factor, glucagon, growth hormone and prolactin. The level of activity in the spleen soluble matrix was not affected by partial hepatectomy or trypsinization. These data indicate that the spleen factor is different from previously characterized effectors of hepatocyte proliferation. The novel factor has been named spleen derived growth factor (SDGF).

Animals↗
PubMed1985

Comparison and definition of spleen and lymph node: a phylogenetic analysis.

The hitherto largely unsolved problem with a biological definition of spleen versus lymph node seems possible to solve from a phylogenetic point of view. Thus, it is suggested that the spleen be defined as a hemopoietic organ which is able to filter blood with sinusoids. In contradistinction, a lymph node is defined as a hemopoietic organ which is able to filter lymph with sinusoids. Comparative anatomical studies show that the spleen appears as a condensation of the lymphomyeloid complex in the spiral fold of the gut in cyclostomes. The spiral fold spleen vanishes with the bony fishes, while in cartilaginous fishes a similar spleen appears in the dorsal mesentery. The dorsal spleen remains in a retroperitoneal position in higher vertebrates and is regarded as a specialized blood vessel compartment closely connected with the blood stream. In "higher" vertebrates the spleen is a stagnated organ because splenic functions are gradually transferred to other sites. The bone marrow takes over the erythro-, thrombo- and granulocytopoiesis while the lymph nodes take over the lymphocytopoiesis. This transfer of the splenic functions is first seen in anurans and seems to be a marvelous adaptation to life on land where the need for local defence against a large number of antigens is necessary before spread of the antigens to central parts of the body. In higher vertebrates, the great number of lymph nodes at peripheral positions, derived from the lymphatic vessels, are able to do so. It is demonstrated that the definitions of spleen and lymph nodes as hemopoietic organs which by their sinusoids are able to filter blood and lymph, respectively, are not only of semantic interest but also useful in regard the immunohematological system as an entity.

Animals↗
PubMed1996

Spleen-preserving distal pancreatectomy with conservation of the splenic artery and vein.

BACKGROUND: The significance of preserving the spleen has recently been shown. However, there are few reports of spleen-preserving distal pancreatectomy for lesions of the body and tail of the pancreas, and this procedure is not generally performed. The aim of this study was to clarify the technique and indications for spleen-preserving distal pancreatectomy with conservation of the splenic artery and vein for benign lesions of the distal pancreas. METHODS: Four patients (two each with an endocrine tumor and a cystic lesion) underwent the procedure. We also performed the spleen-preserving Puestow's procedure with removal of the tail of the pancreas in a 22-year-old male patient with familial chronic pancreatitis. An important technique is to remove the splenic vein from the pancreas from the body of the pancreas toward the spleen and to remove the splenic artery from the pancreas in the other direction. The splenic vein is identified behind the pancreas and within the thin connective tissue membrane, which is cut longitudinally above the splenic vein. It is important to remove the splenic vein from the pancreas from the body of the pancreas toward the spleen, because it is very difficult to remove it in the other direction. There are many branches from the splenic vein on both sides; these branches should be carefully ligated and cut. The pancreas is removed from the splenic artery from the spleen toward the head of the pancreas. This procedure is much easier than removal of the pancreas from the vein. RESULTS: The postoperative course was uneventful in four of the five patients. A pancreatic fistula remained in one patient for several weeks. The mean and standard deviation of the operative blood loss, the duration of the operation, and the postoperative hospital stay in the four uneventful cases, excluding the one in which Puestow's procedure was performed, were 600 +/- 479 ml, 290 +/- 48 minutes, and 40 +/- 21 days, respectively. No severe complications occurred in any of the five patients. CONCLUSIONS: Spleen-preserving distal pancreatectomy with conservation of the splenic artery and vein is easy and safe and should be performed for benign lesions of the distal pancreas.

Adult↗
PubMed2003

Up-regulation of transforming growth factor-beta 1 in the spleen of aniline-treated rats.

Aniline exposure produces selective toxicity to the spleen, leading to a variety of sarcomas in rats following chronic exposure. Fibrosis appears to be an important preneoplastic lesion of the spleen. However, early molecular events leading to splenic fibrosis are not known. Earlier studies have shown that aniline exposure in rats leads to excessive deposition of iron and increased lipid peroxidation in the spleen, which may produce changes in the expression of fibrogenic cytokines, such as transforming growth factor-beta 1 (TGF-beta 1), leading to splenic fibrosis. Therefore, this study was designed to establish whether aniline exposure leads to induction/overexpression of TGF-beta 1 and association of such induction with lipid peroxidation (oxidative stress) in the spleen. To achieve this, male Sprague-Dawley rats were given 1 mmol/kg/day aniline hydrochloride in water by gavage for 7 days, while controls received water only. Aniline treatment resulted in significant increases in spleen weight (97%), spleen-to-body weight ratios (104%), and splenocyte population (25%). Malondialdehyde-protein adducts, quantitated by a competitive ELISA, showed a 56% increase in the spleen of aniline-treated rats. TGF-beta 1, measured in the supernatants of cultured splenocytes by an ELISA specific for TGF-beta 1, showed a significant increase (60%) in the total TGF-beta 1 from aniline-treated rats. These increases were further confirmed by Western blot analysis, which showed approximately 2.5-fold increase in cell-associated TGF-beta 1 protein expression in aniline-treated rats. Furthermore, determination of TGF-beta 1 mRNA expression showed a 4-fold increase in the spleens of aniline-treated rats. These results suggest an association between formation of MDA-protein adducts and overexpression of TGF-beta 1 as a result of aniline insult, which together could promote splenic injury and fibrogenesis.

Aniline Compounds↗